FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:1838-1849 April 29, 2004 Number 18 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Supplementary Material Perspective by Gribble, F. M. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article PubMed Citation

ABSTRACT

Background Patients with permanent neonatal diabetes usually present within the first three months of life and require insulin treatment. In most, the cause is unknown. Because ATP-sensitive potassium (K_ATP) channels mediate glucose-stimulated insulin secretion from the pancreatic beta cells, we hypothesized that activating mutations in the gene encoding the Kir6.2 subunit of this channel (KCNJ11) cause neonatal diabetes.

Methods We sequenced the KCNJ11 gene in 29 patients with permanent neonatal diabetes. The insulin secretory response to intravenous glucagon, glucose, and the sulfonylurea tolbutamide was assessed in patients who had mutations in the gene.

Results Six novel, heterozygous missense mutations were identified in 10 of the 29 patients. In two patients the diabetes was familial, and in eight it arose from a spontaneous mutation. Their neonatal diabetes was characterized by ketoacidosis or marked hyperglycemia and was treated with insulin. Patients did not secrete insulin in response to glucose or glucagon but did secrete insulin in response to tolbutamide. Four of the patients also had severe developmental delay and muscle weakness; three of them also had epilepsy and mild dysmorphic features. When the most common mutation in Kir6.2 was coexpressed with sulfonylurea receptor 1 in Xenopus laevis oocytes, the ability of ATP to block mutant K_ATP channels was greatly reduced.

Conclusions Heterozygous activating mutations in the gene encoding Kir6.2 cause permanent neonatal diabetes and may also be associated with developmental delay, muscle weakness, and epilepsy. Identification of the genetic cause of permanent neonatal diabetes may facilitate the treatment of this disease with sulfonylureas.

Source Information

From the Institute of Biomedical and Clinical Science, Peninsula Medical School, Exeter, United Kingdom (A.L.G., E.R.P., E.L.E., T.M.F., S.E., A.T.H.); the University Laboratory of Physiology, Oxford University, Oxford, United Kingdom (J.F.A., P.P., F.M.A.); Sophia Children's Hospital, Rotterdam, the Netherlands, (G.J.B., A.S.S.); the Institute of Endocrinology and Diabetes, Children's Hospital at Westmead, Westmead, Australia (N.H., S.S.); Piaui State University Medical School, Teresina, Piaui, Brazil (J.M.C.L.S.); the Institute for Clinical Medicine and Molecular Medicine, University of Bergen, Bergen, Norway (J.M., P.R.N.); Wessex Clinical Genetics Service and the Division of Human Genetics, Southampton University and Hospitals, National Health Service Trust, Southampton, United Kingdom (I.K.T.); Wessex Regional Genetics Laboratories, Salisbury District Hospital, Salisbury, United Kingdom (D.M.); Royal Hospital for Children, Bristol, United Kingdom (J.P.H.S.); Second Department of Pediatrics and Second Faculty of Medicine, Charles University, Prague, Czech Republic (Z.S.); Meander Medical Center, Amersfoort, the Netherlands (A.R.); Academic Unit of Child Health, Sheffield Children's Hospital, Sheffield, United Kingdom (J.K.H.W.); Regional Endocrine Laboratory, Birmingham, United Kingdom (P.C.); St. Luke's Hospital, Bradford, United Kingdom (S.G.); and the Division of Pediatric Endocrinology and Diabetes, Hackensack University Medical Center, Hackensack, N.J. (J.A.).

Address reprint requests to Dr. Hattersley at Diabetes and Vascular Medicine, Institute of Biomedical and Clinical Science, Peninsula Medical School, Barrack Rd., Exeter EX2 5AX, United Kingdom, or at a.t.hattersley{at}ex.ac.uk.

Full Text of this Article

This article has been cited by other articles:

• Koster, J. C., Kurata, H. T., Enkvetchakul, D., Nichols, C. G. (2008). DEND Mutation in Kir6.2 (KCNJ11) Reveals a Flexible N-Terminal Region Critical for ATP-Sensing of the KATP Channel. Biophys. J 95: 4689-4697 [Abstract] [Full Text]  
• Gajdos, Z. K. Z., Butler, J. L., Henderson, K. D., He, C., Supelak, P. J., Egyud, M., Price, A., Reich, D., Clayton, P. E., Le Marchand, L., Hunter, D. J., Henderson, B. E., Palmert, M. R., Hirschhorn, J. N. (2008). Association Studies of Common Variants in 10 Hypogonadotropic Hypogonadism Genes with Age at Menarche. J. Clin. Endocrinol. Metab. 93: 4290-4298 [Abstract] [Full Text]  
• McCarthy, M. I., Hattersley, A. T. (2008). Learning From Molecular Genetics: Novel Insights Arising From the Definition of Genes for Monogenic and Type 2 Diabetes. Diabetes 57: 2889-2898 [Full Text]  
• Esmatjes, E., Jimenez, A., Diaz, G., Mora, M., Casamitjana, R., Perez de Nanclares, G., Castano, L., Jose Ricart, M. (2008). Neonatal Diabetes With End-Stage Nephropathy: Pancreas transplantation decision. Diabetes Care 31: 2116-2117 [Abstract] [Full Text]  
• McCarthy, M. I., Hirschhorn, J. N. (2008). Genome-wide association studies: potential next steps on a genetic journey. Hum Mol Genet 17: R156-R165 [Abstract] [Full Text]  
• Velisek, L., Veliskova, J., Chudomel, O., Poon, K.-L., Robeson, K., Marshall, B., Sharma, A., Moshe, S. L. (2008). Metabolic Environment in Substantia Nigra Reticulata Is Critical for the Expression and Control of Hypoglycemia-Induced Seizures. J. Neurosci. 28: 9349-9362 [Abstract] [Full Text]  
• Heitzmann, D., Warth, R. (2008). Physiology and Pathophysiology of Potassium Channels in Gastrointestinal Epithelia. Physiol. Rev. 88: 1119-1182 [Abstract] [Full Text]  
• Webster, N. J., Searle, G. J., Lam, P. P. L., Huang, Y.-C., Riedel, M. J., Harb, G., Gaisano, H. Y., Holt, A., Light, P. E. (2008). Elevation in Intracellular Long-Chain Acyl-Coenzyme A Esters Lead to Reduced {beta}-Cell Excitability via Activation of Adenosine 5'-Triphosphate-Sensitive Potassium Channels. Endocrinology 149: 3679-3687 [Abstract] [Full Text]  
• Abdulhadi-Atwan, M., Bushman, J. D., Tornovsky-Babaey, S., Perry, A., Abu-Libdeh, A., Glaser, B., Shyng, S.-L., Zangen, D. H. (2008). Novel De Novo Mutation in Sulfonylurea Receptor 1 Presenting as Hyperinsulinism in Infancy Followed by Overt Diabetes in Early Adolescence. Diabetes 57: 1935-1940 [Abstract] [Full Text]  
• Tarasov, A. I., Nicolson, T. J., Riveline, J.-P., Taneja, T. K., Baldwin, S. A., Baldwin, J. M., Charpentier, G., Gautier, J.-F., Froguel, P., Vaxillaire, M., Rutter, G. A. (2008). A Rare Mutation in ABCC8/SUR1 Leading to Altered ATP-Sensitive K+ Channel Activity and {beta}-Cell Glucose Sensing Is Associated With Type 2 Diabetes in Adults. Diabetes 57: 1595-1604 [Abstract] [Full Text]  
• Chen, R., Hussain, K., Al-Ali, M., Dattani, M. T., Hindmarsh, P., Jones, P. M., Marsh, P. (2008). Neonatal and Late-Onset Diabetes Mellitus Caused by Failure of Pancreatic Development: Report of 4 More Cases and a Review of the Literature. Pediatrics 121: e1541-e1547 [Abstract] [Full Text]  
• Aguilar-Bryan, L., Bryan, J. (2008). Neonatal Diabetes Mellitus. Endocr. Rev. 29: 265-291 [Abstract] [Full Text]  
• Lin, Y.-W., Bushman, J. D., Yan, F.-F., Haidar, S., MacMullen, C., Ganguly, A., Stanley, C. A., Shyng, S.-L. (2008). Destabilization of ATP-sensitive Potassium Channel Activity by Novel KCNJ11 Mutations Identified in Congenital Hyperinsulinism. J. Biol. Chem. 283: 9146-9156 [Abstract] [Full Text]  
• Glaser, B. (2008). Insulin Mutations in Diabetes: The Clinical Spectrum. Diabetes 57: 799-800 [Full Text]  
• Edghill, E. L., Flanagan, S. E., Patch, A.-M., Boustred, C., Parrish, A., Shields, B., Shepherd, M. H., Hussain, K., Kapoor, R. R., Malecki, M., MacDonald, M. J., Stoy, J., Steiner, D. F., Philipson, L. H., Bell, G. I., the Neonatal Diabetes International Collaborative, , Hattersley, A. T., Ellard, S. (2008). Insulin Mutation Screening in 1,044 Patients With Diabetes: Mutations in the INS Gene Are a Common Cause of Neonatal Diabetes but a Rare Cause of Diabetes Diagnosed in Childhood or Adulthood. Diabetes 57: 1034-1042 [Abstract] [Full Text]  
• Molven, A., Ringdal, M., Nordbo, A. M., Raeder, H., Stoy, J., Lipkind, G. M., Steiner, D. F., Philipson, L. H., Bergmann, I., Aarskog, D., Undlien, D. E., Joner, G., Sovik, O., the Norwegian Childhood Diabetes Study Group, , Bell, G. I., Njolstad, P. R. (2008). Mutations in the Insulin Gene Can Cause MODY and Autoantibody-Negative Type 1 Diabetes. Diabetes 57: 1131-1135 [Abstract] [Full Text]  
• Koster, J. C., Cadario, F., Peruzzi, C., Colombo, C., Nichols, C. G., Barbetti, F. (2008). The G53D Mutation in Kir6.2 (KCNJ11) Is Associated with Neonatal Diabetes and Motor Dysfunction in Adulthood that Is Improved with Sulfonylurea Therapy. J. Clin. Endocrinol. Metab. 93: 1054-1061 [Abstract] [Full Text]  
• Rafiq, M., Flanagan, S. E., Patch, A.-M., Shields, B. M., Ellard, S., Hattersley, A. T., The Neonatal Diabetes International Collaborative, (2008). Effective Treatment With Oral Sulfonylureas in Patients With Diabetes Due to Sulfonylurea Receptor 1 (SUR1) Mutations. Diabetes Care 31: 204-209 [Abstract] [Full Text]  
• Shield, J. P.H., Flanagan, S. E., Mackay, D. J., Harries, L. W., Proks, P., Girard, C., Ashcroft, F. M., Temple, I. K., Ellard, S. (2008). Mosaic Paternal Uniparental Isodisomy and an ABCC8 Gene Mutation in a Patient With Permanent Neonatal Diabetes and Hemihypertrophy. Diabetes 57: 255-258 [Abstract] [Full Text]  
• de Wet, H., Rees, M. G., Shimomura, K., Aittoniemi, J., Patch, A.-M., Flanagan, S. E., Ellard, S., Hattersley, A. T., Sansom, M. S. P., Ashcroft, F. M. (2007). Increased ATPase activity produced by mutations at arginine-1380 in nucleotide-binding domain 2 of ABCC8 causes neonatal diabetes. Proc. Natl. Acad. Sci. USA 104: 18988-18992 [Abstract] [Full Text]  
• Zingman, L. V., Alekseev, A. E., Hodgson-Zingman, D. M., Terzic, A. (2007). ATP-sensitive potassium channels: metabolic sensing and cardioprotection. J. Appl. Physiol. 103: 1888-1893 [Abstract] [Full Text]  
• Nichols, C. G. (2007). Alchemy in the Soup: Transforming Metabolic Signals to Excitability. Sci Signal 2007: pe59-pe59 [Abstract] [Full Text]  
• Polak, M. (2007). Neonatal Diabetes Mellitus: Insights for More Common Forms of Diabetes. J. Clin. Endocrinol. Metab. 92: 3774-3776 [Full Text]  
• Suzuki, S., Makita, Y., Mukai, T., Matsuo, K., Ueda, O., Fujieda, K. (2007). Molecular Basis of Neonatal Diabetes in Japanese Patients. J. Clin. Endocrinol. Metab. 92: 3979-3985 [Abstract] [Full Text]  
• Ashcroft, F. M. (2007). ATP-sensitive K+ channels and disease: from molecule to malady. Am. J. Physiol. Endocrinol. Metab. 293: E880-E889 [Abstract] [Full Text]  
• Cooper, E. C., Pan, Z. (2007). Putting an end to DEND: A severe neonatal-onset epilepsy is treatable if recognized early. Neurology 69: 1310-1311 [Full Text]  
• Shimomura, K., Horster, F., de Wet, H., Flanagan, S. E., Ellard, S., Hattersley, A. T., Wolf, N. I., Ashcroft, F., Ebinger, F. (2007). A novel mutation causing DEND syndrome: A treatable channelopathy of pancreas and brain. Neurology 69: 1342-1349 [Abstract] [Full Text]  
• Stoy, J., Edghill, E. L., Flanagan, S. E., Ye, H., Paz, V. P., Pluzhnikov, A., Below, J. E., Hayes, M. G., Cox, N. J., Lipkind, G. M., Lipton, R. B., Greeley, S. A. W., Patch, A.-M., Ellard, S., Steiner, D. F., Hattersley, A. T., Philipson, L. H., Bell, G. I., Neonatal Diabetes International Collaborative Grou, (2007). Insulin gene mutations as a cause of permanent neonatal diabetes. Proc. Natl. Acad. Sci. USA 104: 15040-15044 [Abstract] [Full Text]  
• Bahi-Buisson, N., Eisermann, M., Nivot, S., Bellanne-Chantelot, C., Dulac, O., Bach, N., Plouin, P., Chiron, C., de Lonlay, P. (2007). Infantile Spasms as an Epileptic Feature of DEND Syndrome Associated With an Activating Mutation in the Potassium Adenosine Triphosphate (ATP) Channel, Kir6.2. J Child Neurol 22: 1147-1150 [Abstract]  
• Enkvetchakul, D., Jeliazkova, I., Bhattacharyya, J., Nichols, C. G. (2007). Control of Inward Rectifier K Channel Activity by Lipid Tethering of Cytoplasmic Domains. JGP 130: 329-334 [Abstract] [Full Text]  
• Proks, P., Shimomura, K., Craig, T. J., Girard, C. A.J., Ashcroft, F. M. (2007). Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome. Hum Mol Genet 16: 2011-2019 [Abstract] [Full Text]  
• Gach, A., Wyka, K., Malecki, M. T., Noczynska, A., Skupien, J., Nazim, J., Szalecki, M., Bodalski, J., Sieradzki, J., Mlynarski, W. (2007). Islet-Specific Antibody Seroconversion in Patients With Long Duration of Permanent Neonatal Diabetes Caused by Mutations in the KCNJ11 Gene. Diabetes Care 30: 2080-2082 [Full Text]  
• Geng, X., Li, L., Bottino, R., Balamurugan, A. N., Bertera, S., Densmore, E., Su, A., Chang, Y., Trucco, M., Drain, P. (2007). Antidiabetic sulfonylurea stimulates insulin secretion independently of plasma membrane KATP channels. Am. J. Physiol. Endocrinol. Metab. 293: E293-E301 [Abstract] [Full Text]  
• Flagg, T. P., Patton, B., Masia, R., Mansfield, C., Lopatin, A. N., Yamada, K. A., Nichols, C. G. (2007). Arrhythmia susceptibility and premature death in transgenic mice overexpressing both SUR1 and Kir6.2[{Delta}N30,K185Q] in the heart. Am. J. Physiol. Heart Circ. Physiol. 293: H836-H845 [Abstract] [Full Text]  
• Nielsen, L. B, Ploug, K. B, Swift, P., Orskov, C., Jansen-Olesen, I., Chiarelli, F., Holst, J. J, Hougaard, P., Porksen, S., Holl, R., de Beaufort, C., Gammeltoft, S., Rorsman, P., Mortensen, H. B, Hansen, L., on behalf of the Hvidore Study Group, (2007). Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes. Eur J Endocrinol 156: 663-671 [Abstract] [Full Text]  
• Vaxillaire, M., Dechaume, A., Busiah, K., Cave, H., Pereira, S., Scharfmann, R., de Nanclares, G. P., Castano, L., Froguel, P., Polak, M., and the SUR1-Neonatal Diabetes Study Group, (2007). New ABCC8 Mutations in Relapsing Neonatal Diabetes and Clinical Features. Diabetes 56: 1737-1741 [Abstract] [Full Text]  
• Edghill, E. L., Gloyn, A. L., Goriely, A., Harries, L. W., Flanagan, S. E., Rankin, J., Hattersley, A. T., Ellard, S. (2007). Origin of de Novo KCNJ11 Mutations and Risk of Neonatal Diabetes for Subsequent Siblings. J. Clin. Endocrinol. Metab. 92: 1773-1777 [Abstract] [Full Text]  
• Codner, E., Flanagan, S. E., Ugarte, F., Garcia, H., Vidal, T., Ellard, S., Hattersley, A. T. (2007). Sulfonylurea Treatment in Young Children With Neonatal Diabetes: Dealing with hyperglycemia, hypoglycemia, and sick days. Diabetes Care 30: e28-e29 [Full Text]  
• Masia, R., De Leon, D. D., MacMullen, C., McKnight, H., Stanley, C. A., Nichols, C. G. (2007). A Mutation in the TMD0-L0 Region of Sulfonylurea Receptor-1 (L225P) Causes Permanent Neonatal Diabetes Mellitus (PNDM). Diabetes 56: 1357-1362 [Abstract] [Full Text]  
• Stanik, J., Gasperikova, D., Paskova, M., Barak, L., Javorkova, J., Jancova, E., Ciljakova, M., Hlava, P., Michalek, J., Flanagan, S. E., Pearson, E., Hattersley, A. T., Ellard, S., Klimes, I. (2007). Prevalence of Permanent Neonatal Diabetes in Slovakia and Successful Replacement of Insulin with Sulfonylurea Therapy in KCNJ11 and ABCC8 Mutation Carriers. J. Clin. Endocrinol. Metab. 92: 1276-1282 [Abstract] [Full Text]  
• Masia, R., Koster, J. C., Tumini, S., Chiarelli, F., Colombo, C., Nichols, C. G., Barbetti, F. (2007). An ATP-Binding Mutation (G334D) in KCNJ11 Is Associated With a Sulfonylurea-Insensitive Form of Developmental Delay, Epilepsy, and Neonatal Diabetes. Diabetes 56: 328-336 [Abstract] [Full Text]  
• Florez, J. C., Jablonski, K. A., Kahn, S. E., Franks, P. W., Dabelea, D., Hamman, R. F., Knowler, W. C., Nathan, D. M., Altshuler, D., for the Diabetes Prevention Program Research Group, (2007). Type 2 Diabetes-Associated Missense Polymorphisms KCNJ11 E23K and ABCC8 A1369S Influence Progression to Diabetes and Response to Interventions in the Diabetes Prevention Program. Diabetes 56: 531-536 [Abstract] [Full Text]  
• Malecki, M. T., Skupien, J., Klupa, T., Wanic, K., Mlynarski, W., Gach, A., Solecka, I., Sieradzki, J. (2007). Transfer to Sulphonylurea Therapy in Adult Subjects With Permanent Neonatal Diabetes Due to KCNJ11-Activating Mutations: Evidence for improvement in insulin sensitivity. Diabetes Care 30: 147-149 [Full Text]  
• Yamada, S., Kane, G. C., Behfar, A., Liu, X.-K., Dyer, R. B., Faustino, R. S., Miki, T., Seino, S., Terzic, A. (2006). Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant. J. Physiol. 577: 1053-1065 [Abstract] [Full Text]  
• Roden, D. M., Altman, R. B., Benowitz, N. L., Flockhart, D. A., Giacomini, K. M., Johnson, J. A., Krauss, R. M., McLeod, H. L., Ratain, M. J., Relling, M. V., Ring, H. Z., Shuldiner, A. R., Weinshilboum, R. M., Weiss, S. T., for the Pharmacogenetics Research Network, (2006). Pharmacogenomics: Challenges and Opportunities.. ANN INTERN MED 145: 749-757 [Abstract] [Full Text]  
• Koster, J. C., Remedi, M. S., Masia, R., Patton, B., Tong, A., Nichols, C. G. (2006). Expression of ATP-Insensitive KATP Channels in Pancreatic {beta}-Cells Underlies a Spectrum of Diabetic Phenotypes. Diabetes 55: 2957-2964 [Abstract] [Full Text]  
• Tarasov, A. I., Welters, H. J., Senkel, S., Ryffel, G. U., Hattersley, A. T., Morgan, N. G., Ashcroft, F. M. (2006). A Kir6.2 Mutation Causing Neonatal Diabetes Impairs Electrical Activity and Insulin Secretion From INS-1 {beta}-Cells. Diabetes 55: 3075-3082 [Abstract] [Full Text]  
• Bonnycastle, L. L., Willer, C. J., Conneely, K. N., Jackson, A. U., Burrill, C. P., Watanabe, R. M., Chines, P. S., Narisu, N., Scott, L. J., Enloe, S. T., Swift, A. J., Duren, W. L., Stringham, H. M., Erdos, M. R., Riebow, N. L., Buchanan, T. A., Valle, T. T., Tuomilehto, J., Bergman, R. N., Mohlke, K. L., Boehnke, M., Collins, F. S. (2006). Common Variants in Maturity-Onset Diabetes of the Young Genes Contribute to Risk of Type 2 Diabetes in Finns. Diabetes 55: 2534-2540 [Abstract] [Full Text]  
• Groves, C. J., Zeggini, E., Minton, J., Frayling, T. M., Weedon, M. N., Rayner, N. W., Hitman, G. A., Walker, M., Wiltshire, S., Hattersley, A. T., McCarthy, M. I. (2006). Association Analysis of 6,736 U.K. Subjects Provides Replication and Confirms TCF7L2 as a Type 2 Diabetes Susceptibility Gene With a Substantial Effect on Individual Risk. Diabetes 55: 2640-2644 [Abstract] [Full Text]  
• Babenko, A. P., Polak, M., Cave, H., Busiah, K., Czernichow, P., Scharfmann, R., Bryan, J., Aguilar-Bryan, L., Vaxillaire, M., Froguel, P. (2006). Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.. NEJM 355: 456-466 [Abstract] [Full Text]  
• Pearson, E. R., Flechtner, I., Njolstad, P. R., Malecki, M. T., Flanagan, S. E., Larkin, B., Ashcroft, F. M., Klimes, I., Codner, E., Iotova, V., Slingerland, A. S., Shield, J., Robert, J.-J., Holst, J. J., Clark, P. M., Ellard, S., Sovik, O., Polak, M., Hattersley, A. T., the Neonatal Diabetes International Collaborative, (2006). Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.. NEJM 355: 467-477 [Abstract] [Full Text]  
• Sperling, M. A. (2006). ATP-sensitive potassium channels--neonatal diabetes mellitus and beyond.. NEJM 355: 507-510 [Full Text]  
• Kane, G. C., Behfar, A., Dyer, R. B., O'Cochlain, D. F., Liu, X.-K., Hodgson, D. M., Reyes, S., Miki, T., Seino, S., Terzic, A. (2006). KCNJ11 gene knockout of the Kir6.2 KATP channel causes maladaptive remodeling and heart failure in hypertension. Hum Mol Genet 15: 2285-2297 [Abstract] [Full Text]  
• Gloyn, A. L., Mackay, D. J.G., Weedon, M. N., McCarthy, M. I., Walker, M., Hitman, G., Knight, B. A., Owen, K. R., Hattersley, A. T., Frayling, T. M. (2006). Assessment of the Role of Common Genetic Variation in the Transient Neonatal Diabetes Mellitus (TNDM) Region in Type 2 Diabetes: A Comparative Genomic and Tagging Single Nucleotide Polymorphism Approach.. Diabetes 55: 2272-2276 [Abstract] [Full Text]  
• Yokoi, N., Kanamori, M., Horikawa, Y., Takeda, J., Sanke, T., Furuta, H., Nanjo, K., Mori, H., Kasuga, M., Hara, K., Kadowaki, T., Tanizawa, Y., Oka, Y., Iwami, Y., Ohgawara, H., Yamada, Y., Seino, Y., Yano, H., Cox, N. J., Seino, S. (2006). Association Studies of Variants in the Genes Involved in Pancreatic {beta}-Cell Function in Type 2 Diabetes in Japanese Subjects.. Diabetes 55: 2379-2386 [Abstract] [Full Text]  
• Slingerland, A. S., Hattersley, A. T. (2006). Activating Mutations in the Gene Encoding Kir6.2 Alter Fetal and Postnatal Growth and Also Cause Neonatal Diabetes. J. Clin. Endocrinol. Metab. 91: 2782-2788 [Abstract] [Full Text]  
• Hathout, E., Mace, J., Bell, G. I., Njolstad, P. R. (2006). Treatment of Hyperglycemia in a 7-Year-Old Child Diagnosed With Neonatal Diabetes.. Diabetes Care 29: 1458-1458 [Full Text]  
• Sesti, G., Laratta, E., Cardellini, M., Andreozzi, F., Del Guerra, S., Irace, C., Gnasso, A., Grupillo, M., Lauro, R., Hribal, M. L., Perticone, F., Marchetti, P. (2006). The E23K Variant of KCNJ11 Encoding the Pancreatic {beta}-Cell Adenosine 5'-Triphosphate-Sensitive Potassium Channel Subunit Kir6.2 Is Associated with an Increased Risk of Secondary Failure to Sulfonylurea in Patients with Type 2 Diabetes. J. Clin. Endocrinol. Metab. 91: 2334-2339 [Abstract] [Full Text]  
• Proks, P., Arnold, A. L., Bruining, J., Girard, C., Flanagan, S. E., Larkin, B., Colclough, K., Hattersley, A. T., Ashcroft, F. M., Ellard, S. (2006). A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes. Hum Mol Genet 15: 1793-1800 [Abstract] [Full Text]  
• Shimomura, K., Girard, C. A.J., Proks, P., Nazim, J., Lippiat, J. D., Cerutti, F., Lorini, R., Ellard, S., Hattersley, A. T., Barbetti, F., Ashcroft, F. M. (2006). Mutations at the Same Residue (R50) of Kir6.2 (KCNJ11) That Cause Neonatal Diabetes Produce Different Functional Effects. Diabetes 55: 1705-1712 [Abstract] [Full Text]  
• Proks, P., Girard, C., Baevre, H., Njolstad, P. R., Ashcroft, F. M. (2006). Functional Effects of Mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), Causing Neonatal Diabetes, and Response to Sulfonylurea Therapy. Diabetes 55: 1731-1737 [Abstract] [Full Text]  
• Lin, C.-W., Lin, Y.-W., Yan, F.-F., Casey, J., Kochhar, M., Pratt, E. B., Shyng, S.-L. (2006). Kir6.2 Mutations Associated With Neonatal Diabetes Reduce Expression of ATP-Sensitive K+ channels: Implications in Disease Mechanism and Sulfonylurea Therapy. Diabetes 55: 1738-1746 [Abstract] [Full Text]  
• Edghill, E. L., Dix, R. J., Flanagan, S. E., Bingley, P. J., Hattersley, A. T., Ellard, S., Gillespie, K. M. (2006). HLA Genotyping Supports a Nonautoimmune Etiology in Patients Diagnosed With Diabetes Under the Age of 6 Months. Diabetes 55: 1895-1898 [Abstract] [Full Text]  
• Hattersley, A. T., Pearson, E. R. (2006). Minireview: Pharmacogenetics and Beyond: The Interaction of Therapeutic Response, {beta}-Cell Physiology, and Genetics in Diabetes. Endocrinology 147: 2657-2663 [Abstract] [Full Text]  
• Tammaro, P., Proks, P., Ashcroft, F. M. (2006). Functional effects of naturally occurring KCNJ11 mutations causing neonatal diabetes on cloned cardiac KATP channels. J. Physiol. 571: 3-14 [Abstract] [Full Text]  
• Kubo, Y., Adelman, J. P., Clapham, D. E., Jan, L. Y., Karschin, A., Kurachi, Y., Lazdunski, M., Nichols, C. G., Seino, S., Vandenberg, C. A. (2005). International Union of Pharmacology. LIV. Nomenclature and Molecular Relationships of Inwardly Rectifying Potassium Channels. Pharmacol. Rev. 57: 509-526 [Full Text]  
• Porter, J R, Barrett, T G (2005). Monogenic syndromes of abnormal glucose homeostasis: clinical review and relevance to the understanding of the pathology of insulin resistance and {beta} cell failure. J. Med. Genet. 42: 893-902 [Abstract] [Full Text]  
• Koster, J. C., Permutt, M. A., Nichols, C. G. (2005). Diabetes and Insulin Secretion: The ATP-Sensitive K+ Channel (KATP) Connection. Diabetes 54: 3065-3072 [Abstract] [Full Text]  
• D'Amato, E., Lorini, R. (2005). Letter re: Neonatal Diabetes Mellitus and Mutation in the HNF-1{beta} Gene. J. Clin. Endocrinol. Metab. 90: 5906-5907 [Full Text]  
• Lin, C.-W., Yan, F., Shimamura, S., Barg, S., Shyng, S.-L. (2005). Membrane Phosphoinositides Control Insulin Secretion Through Their Effects on ATP-Sensitive K+ Channel Activity. Diabetes 54: 2852-2858 [Abstract] [Full Text]  
• Remedi, M. S., Koster, J. C., Patton, B. L., Nichols, C. G. (2005). ATP-Sensitive K+ Channel Signaling in Glucokinase-Deficient Diabetes. Diabetes 54: 2925-2931 [Abstract] [Full Text]  
• Proks, P., Girard, C., Ashcroft, F. M. (2005). Functional effects of KCNJ11 mutations causing neonatal diabetes: enhanced activation by MgATP. Hum Mol Genet 14: 2717-2726 [Abstract] [Full Text]  
• Hattersley, A. T., Ashcroft, F. M. (2005). Activating Mutations in Kir6.2 and Neonatal Diabetes: New Clinical Syndromes, New Scientific Insights, and New Therapy. Diabetes 54: 2503-2513 [Abstract] [Full Text]  
• Koster, J. C., Remedi, M. S., Dao, C., Nichols, C. G. (2005). ATP and Sulfonylurea Sensitivity of Mutant ATP-Sensitive K+ Channels in Neonatal Diabetes: Implications for Pharmacogenomic Therapy. Diabetes 54: 2645-2654 [Abstract] [Full Text]  
• Li, L., Geng, X., Yonkunas, M., Su, A., Densmore, E., Tang, P., Drain, P. (2005). Ligand-dependent Linkage of the ATP Site to Inhibition Gate Closure in the KATP Channel. JGP 126: 285-299 [Abstract] [Full Text]  
• Yorifuji, T., Nagashima, K., Kurokawa, K., Kawai, M., Oishi, M., Akazawa, Y., Hosokawa, M., Yamada, Y., Inagaki, N., Nakahata, T. (2005). The C42R Mutation in the Kir6.2 (KCNJ11) Gene as a Cause of Transient Neonatal Diabetes, Childhood Diabetes, or Later-Onset, Apparently Type 2 Diabetes Mellitus. J. Clin. Endocrinol. Metab. 90: 3174-3178 [Abstract] [Full Text]  
• Hansen, S. K., Nielsen, E.-M. D., Ek, J., Andersen, G., Glumer, C., Carstensen, B., Mouritzen, P., Drivsholm, T., Borch-Johnsen, K., Jorgensen, T., Hansen, T., Pedersen, O. (2005). Analysis of Separate and Combined Effects of Common Variation in KCNJ11 and PPARG on Risk of Type 2 Diabetes. J. Clin. Endocrinol. Metab. 90: 3629-3637 [Abstract] [Full Text]  
• Gloyn, A. L., Reimann, F., Girard, C., Edghill, E. L., Proks, P., Pearson, E. R., Temple, I. K., Mackay, D. J.G., Shield, J. P.H., Freedenberg, D., Noyes, K., Ellard, S., Ashcroft, F. M., Gribble, F. M., Hattersley, A. T. (2005). Relapsing diabetes can result from moderately activating mutations in KCNJ11. Hum Mol Genet 14: 925-934 [Abstract] [Full Text]  
• Meyre, D., Boutin, P., Tounian, A., Deweirder, M., Aout, M., Jouret, B., Heude, B., Weill, J., Tauber, M., Tounian, P., Froguel, P. (2005). Is Glutamate Decarboxylase 2 (GAD2) a Genetic Link between Low Birth Weight and Subsequent Development of Obesity in Children?. J. Clin. Endocrinol. Metab. 90: 2384-2390 [Abstract] [Full Text]  
• Codner, E., Flanagan, S., Ellard, S., Garcia, H., Hattersley, A. T. (2005). High-Dose Glibenclamide Can Replace Insulin Therapy Despite Transitory Diarrhea in Early-Onset Diabetes Caused by a Novel R201L Kir6.2 Mutation. Diabetes Care 28: 758-759 [Full Text]  
• Proks, P., Antcliff, J. F., Lippiat, J., Gloyn, A. L., Hattersley, A. T., Ashcroft, F. M. (2004). Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features. Proc. Natl. Acad. Sci. USA 101: 17539-17544 [Abstract] [Full Text]  
• Porter, J R, Barrett, T G (2004). Acquired non-type 1 diabetes in childhood: subtypes, diagnosis, and management. Arch. Dis. Child. 89: 1138-1144 [Abstract] [Full Text]  
• Bryan, J., Vila-Carriles, W. H., Zhao, G., Babenko, A. P., Aguilar-Bryan, L. (2004). Toward Linking Structure With Function in ATP-Sensitive K+ Channels. Diabetes 53: S104-S112 [Abstract] [Full Text]  
• Tarasov, A., Dusonchet, J., Ashcroft, F. (2004). Metabolic Regulation of the Pancreatic Beta-Cell ATP-Sensitive K+ Channel: A Pas de Deux. Diabetes 53: S113-S122 [Abstract] [Full Text]  
• Thomas, H., Senkel, S., Erdmann, S., Arndt, T., Turan, G., Klein-Hitpass, L., Ryffel, G. U. (2004). Pattern of genes influenced by conditional expression of the transcription factors HNF6, HNF4{alpha} and HNF1{beta} in a pancreatic {beta}-cell line. Nucleic Acids Res 32: e150-e150 [Abstract] [Full Text]  
• Edghill, E. L., Gloyn, A. L., Gillespie, K. M., Lambert, A. P., Raymond, N. T., Swift, P. G., Ellard, S., Gale, E. A.M., Hattersley, A. T. (2004). Activating Mutations in the KCNJ11 Gene Encoding the ATP-Sensitive K+ Channel Subunit Kir6.2 Are Rare in Clinically Defined Type 1 Diabetes Diagnosed Before 2 Years. Diabetes 53: 2998-3001 [Abstract] [Full Text]  
• (2004). Lucina. Arch. Dis. Child. 89: 1080-1080 [Full Text]  
• Sagen, J. V., Raeder, H., Hathout, E., Shehadeh, N., Gudmundsson, K., Baevre, H., Abuelo, D., Phornphutkul, C., Molnes, J., Bell, G. I., Gloyn, A. L., Hattersley, A. T., Molven, A., Sovik, O., Njolstad, P. R. (2004). Permanent Neonatal Diabetes due to Mutations in KCNJ11 Encoding Kir6.2: Patient Characteristics and Initial Response to Sulfonylurea Therapy. Diabetes 53: 2713-2718 [Abstract] [Full Text]  
• Vaxillaire, M., Populaire, C., Busiah, K., Cave, H., Gloyn, A. L., Hattersley, A. T., Czernichow, P., Froguel, P., Polak, M. (2004). Kir6.2 Mutations Are a Common Cause of Permanent Neonatal Diabetes in a Large Cohort of French Patients. Diabetes 53: 2719-2722 [Abstract] [Full Text]